Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

FinlandBack to Finland

Clinical trials in Oulu – page 8

183 clinical trials in Oulu, Finland across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Oulu at a glance
183
clinical trials
  • Research sites5
Type of trial
Recruitment status
Quick filters

183 trials in Oulu

Open in trial search

Pneumococcal immunisation

Not yet recruiting

Safety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:Pfizer Inc.

Embolism venous

Not yet recruiting

Apixaban for Preventing Blood Clots in Adults Receiving Neoadjuvant Therapy for Muscle‑Invasive Bladder Cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:HUS-Yhtymae

Urinary tract infection

Not yet recruiting

Preventing urinary tract infections in infants and children under 2 years with oral Escherichia coli strain Nissle 1917 probiotic: a randomized controlled trial

Registered drug
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Escherichia coli strain Nissle 1917
  • Sponsor:Pohjois-Pohjanmaan hyvinvointialue

Major depression

Not yet recruiting

Long‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder

InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.

Contraception

Not yet recruiting

A study comparing the effects of estetrol and drospirenone, ethinylestradiol and drospirenone, and drospirenone in women with polycystic ovary syndrome (PCOS)

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · Healthy volunteers
  • Substances:Drospirenone
  • Sponsor:Pohjois-Pohjanmaan hyvinvointialue

Contraception

Not yet recruiting

Contraception study in women: comparing oral drospirenone‑only, drospirenone + ethinylestradiol, and drospirenone + estetrol tablets

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · Healthy volunteers
  • Substances:Drospirenone
  • Sponsor:Pohjois-Pohjanmaan hyvinvointialue

Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia

Not yet recruiting
Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Major depression

Not yet recruiting

A study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder

Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.

Acute respiratory distress syndrome

Not yet recruiting

Study on Premedication with Ketamine or Fentanyl for Patients with Respiratory Distress Syndrome Receiving Surfactant Treatment

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Fentanyl Citrate
  • Sponsor:Pohjois-Pohjanmaan hyvinvointialue

Appendicitis

Not yet recruiting

Study Comparing Antibiotic Treatment with Placebo for Patients with Acute Appendicitis Using Ertapenem, Metronidazole, and Levofloxacin

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Ertapenem
  • Sponsor:Turku University Hospital

Central nervous system lymphoma

Not yet recruiting

Study on the Effectiveness of Etoposide Phosphate, Carboplatin, Methotrexate, Rituximab, and Cyclophosphamide in Patients with Primary Central Nervous System Lymphoma

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Oulu University Hospital

Frostbite

Not yet recruiting

Study on Frostbite Treatment for Severe Cases Using Alteplase and Iloprost

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:HUS-Yhtymae

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Oulu

What the registry says about research in the country

01 Infectious Disease Prevention

Innovative clinical trials focusing on vaccine development against various infectious diseases, including studies of RSV, influenza, and meningococcal vaccines for different age groups.

  • Respiratory Syncytial Virus (RSV) Prevention
  • Influenza Vaccine Development
  • Meningococcal Disease Protection

Multiple studies evaluating immune responses and safety profiles in both pediatric and elderly populations.

02 Cancer Research

Advanced trials in oncology, with particular focus on prostate cancer and lymphoma treatments, including innovative approaches to central nervous system malignancies.

  • Metastatic Prostate Cancer
  • Primary CNS Lymphoma
  • Follicular Lymphoma

Studies combining chemotherapy with novel therapeutic approaches for improved patient outcomes.

03 Surgical and Emergency Medicine

Research examining surgical interventions and emergency treatments, including studies on appendicitis management and advanced imaging techniques for acute conditions.

  • Acute Appendicitis Treatment
  • Frostbite Therapy
  • Gastric Cancer Surgery

Comparative studies of surgical versus non-surgical approaches in acute medical conditions.

Back to FinlandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.